
NK (natural killer) cells are lymphocytes distinct from B and T cells that induce perforin-mediated lysis of tumor cells and virus-infected cells. NK cell-mediated cytotoxicity is activated by glycoproteins on the cell surface (activating receptors) and inhibited by MHC-1 with self-peptide bound. The MHC-1 inhibitory signal through Ig-family or lectin receptors prevents NK cells from killing normal cells. Abnormal MHC-1 expression in infected or tumor cells results in the release of perforin, the lysis of the abnormal cell and the release of cytokines that stimulate the immune response. MAP kinase inhibitors but not ras inhibitors are able to block NK cell cytotoxicity, indicating that the pathway can function by a ras-independent manner that involves the MAP kinase pathway. This pathway includes phosphoinositide-3-kinase (PI3K) as a key component, followed by Rac1 and the exchange factor Vav. The tyrosine kinase SYK and LAT may provide an additional pathway for activation of MAP kinases leading to NK cell activation, and also Pyk-2 activation by integrins. The protein tyrosine phosphatase SHP-1 appears to mediate the cytotoxicity inhibitory signal that blocks lysis of normal cells. The balance of these positive and negative signaling pathways regulates the role of NK cells in the immune response.
Contributor: Glenn Croston, PhD
REFERENCES: Brumbaugh KM et al., J Exp Med 1997 Dec 15;186(12):1965-74, Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. Galandrini R, Palmieri G, Piccoli M, Frati L, Santoni A., J Immunol 1999 Mar 15;162(6):3148-52, Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. Gismondi A et al., J Immunol 2000 Mar 1;164(5):2272-6, Cutting edge: functional role for proline-rich tyrosine kinase 2 in NK cell-mediated natural cytotoxicity. Jiang K et al., Nat Immunol 2000 Nov;1(5):419-25, Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Wei S, Gilvary DL, Corliss BC, Sebti S, Sun J, Straus DB, Leibson PJ, Trapani JA, Hamilton AD, Weber MJ, Djeu JY., J Immunol 2000 Oct 1;165(7):3811-9, Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway.
萬物蓬勃的7月里迎來了2022年ANTOP獎的申報和評審工作。由島津企業管理(中國)有限公司申報的“3CoinONE全新體驗氣袋進樣器”ANTOP獎進入專家評審階段。獎項名稱:3CoinONE全新體驗......
青島青源峰達太赫茲科技有限公司研發團隊在國際頂級期刊《TrendsinBiotechnology》(譯名:《生物技術趨勢》)在線發表題為“THzmedicalimaging:frominvitroto......
安進宣布,美國FDA授予其在研firstinclass單抗bemarituzumab突破性療法認定,與改良FOLFOX6化療方案(亞葉酸鈣、氟尿嘧啶和奧沙利鉑)聯用,一線治療FGFR2b過表達和HER......
2007年,中國科學院金屬研究所研究員張志東在英國《哲學雜志》(PhilosophicalMagazine)上發表論文,提出兩個猜想,并在猜想基礎上推定出三維伊辛模型的精確解。被《哲學雜志》審稿人評價......
自然殺傷細胞(Naturalkillercells,NKcells)是一種效應性淋巴細胞,在人體抗腫瘤過程中發揮重要作用,但是,仍然有一些腫瘤細胞能夠逃避機體NK細胞的攻擊,逐步發生發展,侵襲轉移,嚴......
天然殺傷細胞(Naturalkillercells,NKcells)是免疫系統的重要組成部分,在機體抗病毒和抗腫瘤中發揮重要作用。NK細胞的發育和功能受到細胞因子、活化性受體和抑制性受體等多種信號調控......
NK(自然殺傷)細胞為先天免疫細胞,能夠識別、殺傷大多數被感染的細胞或腫瘤細胞,其活性不受MHC限制,不需要抗體,對腫瘤和感染細胞的免疫防御具有重要作用。NK細胞來源于造血干細胞,經過一系列的發育階段......
2019年8月13日,NKMaxAmerica,一家開發NK(自然殺傷)細胞療法的生物技術公司,宣布啟動SNK01-US01的I期臨床試驗,SNK是一種離體擴增的自體的NK細胞療法,用于難治性癌癥治療......
NK細胞,又稱自然殺傷細胞(NaturalKillerCells),是白細胞的一種,在免疫系統的抗癌斗爭中發揮著重要作用。基于T細胞的癌癥免疫療法已經在血液腫瘤領域大放異彩。然而,由于制備功能細胞等問......
近日,Cell出版集團旗下免疫學期刊Immunity刊登了中國科學技術大學生命科學與醫學部、中國科學院天然免疫與慢性疾病重點實驗室和合肥微尺度物質科學國家研究中心田志剛課題組的研究論文“Liver-r......